Atlas Trials

Dexmedetomidine Alleviates Postoperative Delirium After Brain Tumor Resections

Clinical trial NCT04674241 · COMPLETED

Trial details

NCT number
NCT04674241
Sponsor
Beijing Tiantan Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
DexmedetomidinePostoperative Delirium
Start date
2021-01-18
Primary completion
2021-12-31
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.